Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Front Public Health ; 12: 1403341, 2024.
Article in English | MEDLINE | ID: mdl-38919928

ABSTRACT

Background: Viral diarrhea is one of the major causes of morbidity and mortality in children. This study aimed to conduct etiological surveillance of viral diarrhea in Zhangzhou city, Fujian province, China, from 2017 to 2019 to identify the prevalence, distribution, and characteristics of viral pathogens causing gastrointestinal infections in the region. Methods: Stool samples were collected from patients with acute diarrhea in Zhangzhou city, Fujian province, China, from 2017 to 2019. Rotavirus, norovirus, astrovirus, and adenovirus were detected using fluorescence immunochromatography assay. Results: Of the total 5,627 samples that were collected, at least one of the viruses (rotavirus, norovirus, astrovirus and adenovirus) was found to be positive in 1,422 samples. Rotavirus, norovirus, astrovirus, and adenovirus, were detected in 53.73, 16.68, 15.52, and 14.97%, respectively. Mixed infections were determined in 17.65% of the positive samples. The predominant mixed infections observed were a combination of norovirus and astrovirus, followed by rotavirus and norovirus, and rotavirus and astrovirus. The highest positive rate was observed in the 12-23-month group for rotavirus and adenovirus, while a significantly higher positive rate was observed for norovirus and astrovirus in the 6-11-month group. Conclusion: These findings from this etiological surveillance highlight the significant burden of viral diarrhea in Zhangzhou city, with rotavirus being the predominant pathogen. The identification of common mixed infections provides insights into the complex nature of viral diarrhea transmission. Target interventions and public health strategies should be implemented, particularly during the winter and spring seasons, to prevent and control the spread of viral pathogens causing gastrointestinal infections in this region.


Subject(s)
Diarrhea , Feces , Norovirus , Humans , China/epidemiology , Diarrhea/epidemiology , Diarrhea/virology , Child, Preschool , Infant , Male , Female , Feces/virology , Child , Norovirus/isolation & purification , Rotavirus/isolation & purification , Prevalence , Virus Diseases/epidemiology , Virus Diseases/virology , Adenoviridae/isolation & purification , Adolescent , Infant, Newborn , Seasons , Coinfection/epidemiology , Coinfection/virology , Adult
2.
Clin Lab ; 68(4)2022 Apr 01.
Article in English | MEDLINE | ID: mdl-35443581

ABSTRACT

BACKGROUND: The goal of the study was to analyze the clinical characteristics of Legionella cases caused by Legionella micdadei and explore the diagnosis and treatment. METHODS: The pathogen was identified by routine isolation and culture, biochemical identification, serum agglutination test, mass spectrometry identification, and routine PCR. Combined with the related literature review, the clinical diagnosis and treatment of Legionella micdadei were analyzed. RESULTS: The patient suffered from pulmonary infection caused by Legionella micdadei. After treatment with moxi-floxacin for 2 weeks, the body temperature dropped and the shadow of the lung was completely absorbed after 2 months. Combined with literature analysis, 8 cases of Legionella micetidis, including 7 males and 1 female, aged from 27 to 57 years old, 6 cases with basic diseases, which were treated with azithromycin, erythromycin or levofloxacin, and all of them achieved good therapeutic effect. CONCLUSIONS: The detection of Legionella should be strengthened in patients with pneumonia whose symptoms have no obvious improvement after antibiotic treatment. Azithromycin, erythromycin or levofloxacin are effective in the treatment of Legionella spp.


Subject(s)
Legionella , Legionellosis , Pneumonia , Adult , Azithromycin/pharmacology , Azithromycin/therapeutic use , Erythromycin/pharmacology , Female , Humans , Legionellaceae , Legionellosis/complications , Legionellosis/diagnosis , Legionellosis/drug therapy , Levofloxacin/pharmacology , Levofloxacin/therapeutic use , Male , Middle Aged , Pneumonia/diagnosis
3.
Technol Cancer Res Treat ; 20: 1533033821995281, 2021.
Article in English | MEDLINE | ID: mdl-33632085

ABSTRACT

OBJECTIVE: We aimed to investigate the diagnostic value of the vaginal microecology, serum miR-18a, and programmed death ligand-1 (PD-L1) for human papillomavirus (HPV)-positive cervical cancer. METHODS: Eighty-four patients with HPV-positive cervical cancer were assigned to the observation group, 107 HPV-positive patients without cervical cancer were assigned to the positive group, and 191 healthy women were assigned to the control group. Vaginal microecology and serum levels of miR-18a and PD-L1 on the surface of CD4+ and CD8+ T cells were compared among the 3 groups. The observation group was further divided into subgroups according to patients' characteristics for comparison. The diagnostic value of miR-18a and PD-L1 for HPV-positive cervical cancer was investigated. RESULTS: Women in the control group had better vaginal microecology and lower levels of miR-18a and PD-L1 than those in the observation and the positive groups (all P < 0.05). Compared with the positive group, the observation group had similar vaginal microecology (all P > 0.05) but higher levels of miR-18a and PD-L1 (all P < 0.05). Moreover, the patients at stage III had higher levels of miR-18a and PD-L1 than those at stage I and II (all P < 0.05). The values of area under the curve for miR-18a and PD-L1 in the diagnosis of HPV-positive cervical cancer were over 0.8 (all P < 0.001). CONCLUSION: Patients with HPV-positive cervical cancer have vaginal microbial dysbiosis and high serum levels of miR-18a and PD-L1. miR-18a and PD-L1 have diagnostic value for identifying HPV-positive cervical cancer.


Subject(s)
B7-H1 Antigen/metabolism , Circulating MicroRNA , MicroRNAs/genetics , Microbiota , Uterine Cervical Neoplasms/diagnosis , Uterine Cervical Neoplasms/etiology , Vagina/microbiology , Adult , Biomarkers, Tumor , Disease Susceptibility , Female , Gene Expression , Humans , Liquid Biopsy , MicroRNAs/blood , Middle Aged , Papillomavirus Infections/complications , Papillomavirus Infections/virology , Prognosis , ROC Curve , T-Lymphocyte Subsets/metabolism , Uterine Cervical Neoplasms/blood
SELECTION OF CITATIONS
SEARCH DETAIL
...